MEDIFER INJECTION
November 10, 2017MEDNISOL INJECTION
November 10, 2017
| ERGO INJECTION |
Methylergometrine Injections |
| Composition : |
Each ampoule contains Methylergometrine Injection BP 0.05% w/v or 500 micrograms of Methylergometrine in 1ml. |
| Indications : |
It is used in the active management of the third stage of labor and in the treatment of post-partum hemorrhage.
|
| Contraindications : |
Hypersensitivity to the active substance or to any of the excipients.
• Pregnancy and labor (induction of labor, first stage labour and second stage labor prior to the delivery of the anterior shoulder) due to the risk of uterine hypertonus and associated foetal complications (see section 4.6 Fertility, pregnancy and lactation).
• Primary or secondary uterine inertia.
• Severe hypertension, pre-eclampsia, eclampsia.
• Severe cardiac disorders.
• Severe hepatic or renal impairment.
• Occlusive vascular disease e.g. Raynaud's disease
|
| Adverse Effects : |
Anaphylactic reactions with associated symptoms of dyspnoea, hypotension, collapse or shock, headache, dizziness, tinnitus, hypertension, vasoconstriction, Dyspnoea, pulmonary oedema, Nausea, vomiting, abdominal pain, skin rash. |
| Dosage : |
Active Management of the Third Stage of Labor:
Ergo Injection is administered (often in combination with synthetic oxytocin 5 units) intramuscularly as a dose of 500 micrograms following the delivery of the anterior shoulder of the infant or at the latest immediately after delivery of the baby.
Prevention and Treatment of Postpartum Hemorrhage:
Doses of 200 micrograms to 500 micrograms of Ergometrine are given intramuscularly, following expulsion of the placenta or when bleeding occurs. In emergencies, Ergometrine Injection may be given intravenously at a dose of 250 micrograms to 500 micrograms.
|
